Proteomics technologies for the study of autoimmune disease.
about
Autoantibody profiling for the study and treatment of autoimmune disease.Protein arrays for studying blood cells and their secreted products.Advances in systems biology approaches for autoimmune diseasesIdentification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays.Current state of diagnostic technologies in the autoimmunology laboratory.Alternative splicing factor ASF/SF2 is down regulated in inflamed muscle.Predictive value of autoantibodies for activity of systemic lupus erythematosus.Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus.Systemic lupus erythematosus and related diseases.An array of possibilities for the study of autoimmunity.Proteomics: an overview.Multiplexed testing in the autoimmunity laboratory.The diagnostic role of autoantibodies in the prediction of organ-specific autoimmune diseases.Proteomic strategies in multiple sclerosis and its animal modelsA novel mechanism of alternative promoter and splicing regulates the epitope generation of tumor antigen CML66-L.Advances in understanding newer autoantibodies and their role as biomarkers in systemic lupus erythematosus.Role of autoimmune responses in periodontal disease.Molecular diagnostics of primary biliary cirrhosis.Melanocortin-4-receptor autoantibodies: a new player in obesity.Autoantibody profiling of patients with autoimmune thyroid disease using a new multiplexed immunoassay method.
P2860
Q24534780-7C9C6D2C-2F90-4138-A96F-1334EF14CCEBQ33213208-647E45FF-00D0-404F-B576-FF3D4221E757Q33619013-9442141E-FB04-4DE5-8029-AF34901A74C3Q34160196-D0EDCFB6-E57C-42A6-AC6E-ACB58AF23896Q34307817-C2F17518-289F-41DF-89BC-C82BB44025CAQ35770262-B71C8D46-720B-41CF-B099-5290013B71AEQ35824462-C0083F22-F11A-4706-B9A5-794FA9DF0FB0Q35824472-9C579324-0D10-4720-AEF6-D3FACBF207A4Q35934706-1BFE072C-6CB4-4245-A755-E1CE290B3DDAQ36148412-9F2A1F36-FF8F-4DA3-B8E5-1CED2CB64761Q36270390-33483CE4-A909-4F5F-97F5-1CA9B67ED91DQ36619605-E28B1678-7CA0-40F7-B3A0-DF96CEEB23BBQ37288640-5B013B9B-C8CD-4E9C-934F-F303606434E8Q37347220-CF9BCF78-D32F-449A-96F0-7153F40CF4CAQ37515426-C01FA367-ABD5-4ABB-8DCF-A0DB6549C024Q38089261-F0FFF7A8-37CD-4930-B941-75D0DBFFC991Q38223097-4032AFD2-019A-4374-8578-811DC8CE8C4AQ40086159-65CAA921-5C9F-4320-B324-B706FF94662DQ43128744-EC0DF83B-C3C4-4714-8BEC-B71E5AC4580EQ55042089-632A6316-F29E-4696-AB53-1084F2791A7D
P2860
Proteomics technologies for the study of autoimmune disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Proteomics technologies for the study of autoimmune disease.
@ast
Proteomics technologies for the study of autoimmune disease.
@en
Proteomics technologies for the study of autoimmune disease.
@nl
type
label
Proteomics technologies for the study of autoimmune disease.
@ast
Proteomics technologies for the study of autoimmune disease.
@en
Proteomics technologies for the study of autoimmune disease.
@nl
prefLabel
Proteomics technologies for the study of autoimmune disease.
@ast
Proteomics technologies for the study of autoimmune disease.
@en
Proteomics technologies for the study of autoimmune disease.
@nl
P2093
P2860
P356
P1476
Proteomics technologies for the study of autoimmune disease.
@en
P2093
Lawrence Steinman
Paul J Utz
William H Robinson
P2860
P304
P356
10.1002/ART.10129
P577
2002-04-01T00:00:00Z